UMPS

Uridine Monophosphate Synthetase

Gene Information Card

Symbol UMPS
Full Name Uridine monophosphate synthetase
Gene Type protein-coding
Chromosomal Location 3q13.32
NCBI Gene ID 7372 ncbi.nlm.nih.gov/gene/7372
Ensembl ID ENSG00000114491
UniProt ID P11172
OMIM ID 613891
HGNC ID 12566
Aliases OPRT, OPRTase, UMPS, OMPdecase, OMPDCase, OPRT, OPRTase, OMPdecase, OMPDCase

Description

The UMPS gene encodes uridine monophosphate synthetase, a bifunctional enzyme that catalyzes the last two steps of de novo pyrimidine biosynthesis: orotate phosphoribosyltransferase (OPRT) and orotidine-5'-phosphate decarboxylase (OMPDC) activities. This enzyme converts orotate to uridine monophosphate (UMP), a precursor for all pyrimidine nucleotides. Deficiency in UMPS leads to hereditary orotic aciduria, a rare autosomal recessive disorder characterized by orotic acid crystalluria, megaloblastic anemia, and developmental delay.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hereditary orotic aciduria Loss-of-function mutations in UMPS impair OPRT and/or OMPDC activities, causing accumulation of orotic acid and deficiency of pyrimidine nucleotides, leading to megaloblastic anemia and orotic acid crystalluria. ClinVar, OMIM
Orotic aciduria type I Deficiency of OPRT activity due to UMPS mutations results in orotic aciduria with megaloblastic anemia. OMIM
Orotic aciduria type II Deficiency of OMPDC activity due to UMPS mutations results in orotic aciduria with megaloblastic anemia. OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Kidney 8.3 Medium
Small intestine 7.1 Medium
Testis 6.8 Medium
Spleen 5.4 Medium
Lung 4.2 Low
Heart 3.9 Low
Brain 2.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 10.2 Liver cancer cell line, high expression
HEK 293 7.5 Embryonic kidney cells, medium expression
K-562 6.0 Leukemia cell line, medium expression
A549 4.8 Lung carcinoma, low expression
MCF7 3.5 Breast cancer, low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.496C>T (p.Arg166*) Nonsense Rare Loss of function; associated with hereditary orotic aciduria
c.638G>A (p.Arg213Gln) Missense Rare Reduced OPRT activity; pathogenic in orotic aciduria
c.1015C>T (p.Arg339Trp) Missense Rare Reduced OMPDC activity; pathogenic in orotic aciduria
c.1A>G (p.Met1?) Start loss Rare Loss of function; associated with hereditary orotic aciduria
Mutation functional classification

Loss of Function (LOF)

Most UMPS mutations are loss-of-function, leading to reduced or absent OPRT and/or OMPDC enzyme activities, causing hereditary orotic aciduria.

Gain of Function (GOF)

No gain-of-function mutations have been reported for UMPS.

Dominant Negative (DN)

No dominant-negative mutations have been reported for UMPS.

Pathways

Pyrimidine metabolism (KEGG: hsa00240)
De novo pyrimidine biosynthesis (Reactome: R-HSA-500753)

Protein Summary

Uridine monophosphate synthetase (UMPS) is a 529-amino acid bifunctional enzyme that catalyzes the final two steps of de novo pyrimidine biosynthesis. The N-terminal domain possesses orotate phosphoribosyltransferase (OPRT) activity, converting orotate and PRPP to orotidine-5'-monophosphate (OMP). The C-terminal domain possesses orotidine-5'-phosphate decarboxylase (OMPDC) activity, converting OMP to uridine monophosphate (UMP). UMP is the precursor for all pyrimidine nucleotides (CTP, TTP, UTP). UMPS is expressed in most tissues, with highest levels in liver and kidney. Deficiency causes hereditary orotic aciduria, treatable with uridine supplementation.

Related Products

Product name Cat.No. Species Gene ID
Contact Us
*
*
*
*
How did you hear about us: